HTL Biotechnology inaugurates a new production line dedicated to sterile Hyaluronic Acid
As part of National Biomanufacturing Day 2025, HTL Biotechnology inaugurates a new production line dedicated to Hyaluronic Acid.
The primary objective of our visit in Korea and China was to engage with our existing clients, forge new business relationships, and explore opportunities for expanding our market presence in these regions.
HTL was pleased to share the latest news from its team, who were in Asia to expand the company’s business in the region.
HTL was delighted by the warm welcome that its team and products received, first in Korea and then in China.
We’re pleased to share our second CSR report, highlighting the actions and commitments we carried out throughout 2024.
A Global Scientific Gathering Dedicated to Hyaluronic Acid Innovation.
As part of National Biomanufacturing Day 2025, HTL Biotechnology inaugurates a new production line dedicated to Hyaluronic Acid.